Welcome to our new website! If this is the first time you are logging in on the new site, you will need to reset your password. Please contact us at raps@raps.org if you need assistance.
The regulatory function is vital in making safe and effective healthcare products available worldwide. Individuals who ensure regulatory compliance and prepare submissions, as well as those whose main job function is clinical affairs or quality assurance are all considered regulatory professionals.
Resources, news and special offers to support you and your professional development during this difficult time.
One of our most valuable contributions to the profession is the Regulatory Code of Ethics. The Code of Ethics provides regulatory professionals with core values that hold them to the highest standards of professional conduct.
Your membership opens the door to free learning resources on demand. Check out the Member Knowledge Center for free webcasts, publications and online courses.
Like all professions, regulatory is based on a shared set of competencies. The Regulatory Competency Framework describes the essential elements of what is required of regulatory professionals at four major career and professional levels.
Convergence 2020 has come and gone, but you can still access recorded sessions, which are available to attendees until 31 December 2020.
This year, our European regulatory community will converge online with a fully virtual program that will allow attendees to experience Euro Convergence live online from the safety and comfort of their homes.
RAPS' “how to” guide to developing a comprehensive global regulatory strategy for all types of medical devices. Updated September 2020.
The last exam window of 2020 is currently open. Register by 8 October to take the RAC exam this autumn.
The site navigation utilizes arrow, enter, escape, and space bar key commands. Left and right arrows move across top level links and expand / close menus in sub levels. Up and Down arrows will open main level menus and toggle through sub tier links. Enter and space open menus and escape closes them as well. Tab will move on to the next part of the site rather than go through menu items.
RAPS is closely monitoring developments in the Coronavirus (COVID-19) outbreak. See our public safety page for the latest updates.
Susana de Azevedo, PhD, Chair Susana de Azevedo Wäsch is a biotechnologist and vice president of quality management and regulatory affairs with Ypsomed AG. She has more than 18 years of experience in medical devices, pharmaceuticals and biotechnology. Wäsch is experienced in the areas of regenerative medicine, implants, drug-device combination products and infusion pumps. Prior to Ypsomed, she worked at Geistlich Pharma AG, Switzerland; Eidgenössische Technische Hochschule Zürich; Lonza Visp, Switzerland; the European Bioinformatics Institute, Cambridge, England; and the Center for Advanced Research in Biotechnology in Rockville, MD, USA. After earning her MSc at the Ecole Supérieure de Biotechnologie Strasbourg, France, she performed her dissertation at the Institute of Microbiology at the Swiss Federal Institute of Technology in Zurich, followed by further training at the Executive School of Management, Technology and Law in St. Gallen, Switzerland.
Jennifer Neff, DVM, PhD, MBA, RAC, Vice Chair Jennifer Neff is director of regulatory and medical affairs at bess AG. She has worked in medical devices, pharmaceuticals and biotechnology for more than 13 years. Prior to bess, Neff held regulatory and clinical affairs positions at Bayer, PAREXEL Consulting, NOXXON Pharma AG, Berlin Heart GmbH and Biotronik GmbH. She has worked with a broad range of devices and drugs. Prior to working in industry, Neff was as a veterinarian in small- and large-animal practice and worked for the primate genetics division of the German Primate Center. She received her PhD from the University of Veterinary Medicine of Hannover and her MBA from FOM University of Applied Sciences in Germany. Neff holds the RAC credential and is the vice chair of the RAP European Council.
Philippe Auclair, PhD Philippe Auclair is senior director, regulatory strategy and advocacy at Abbott. He represents European industry in various European Commission expert groups and actively participates as a trainer in programs organized by regulatory authorities in various geographies. Auclair has served since 2015 as an advisor to the Asian Harmonization Working Party Technical Committee. He is Chairman of the postmarket surveillance and notified body working groups of the European medical device manufacturers’ trade association, Medtech Europe. Auclair received RAPS’ Global Leadership Award in 2010, was selected RAPS Fellow in 2012 and is also the proud recipient of an FDA CDRH director’s “Special Citation” for his work with the Global Harmonization Task Force (GHTF).
Lena Cordie-Bancroft Lena Cordie-Bancroft is the president and principal consultant at Qualitas Professional Service, where she works with medical device and IVD companies to implement ISO 13485 and FDA-QS-regulation-compliant quality management systems supporting processes to comply with FDA and international regulatory requirements. Cordie-Bancroft helps clients with quality systems, risk management and global regulatory compliance related to labeling and Unique Device Identification (UDI) requirements. She is a member of Association for the Advancement of Medical Instrumentation (AAMI) Sterilization Standards Committee, ISO/TC 198 and ISO/TC 210 work groups. She is an active member of RAPS, chairperson for the RAPS Twin Cities Chapter, member of the RAPS European Council and a leader of the UK Local Networking Group.
Roy Jamieson Roy Jamieson is an independent regulatory chemistry, manufacturing and controls (CMC) consultant at Jamieson Combinations AB. He is a pharmacist with extensive, wide-ranging experience in the pharmaceutical industry, as well as an experienced regulatory quality/CMC professional. Jamieson has served as a reviewer at the UK’s Medicines and Healthcare products Regulatory Agency and spent more than 20 years with large pharmaceutical companies leading numerous global projects from First Time in Human studies through Marketing Authorisation and launch. Jamieson’s key area of expertise centers on biopharmaceutics aspects of solid oral dosage forms and the bridge between quality performance and the pharmacokinetic profile linked to safety and efficacy, covering critical review aspects enabling access to high quality medicines. He also maintains a keen interest in the progress of African regulatory harmonization.
Michael Maier Michael Maier has more than 20 years of hands-on experience in the medical device industry working on design and development projects, product industrialization, and regulatory and quality affairs. He is a trained notified body auditor for ISO 13485 and the EU Medical Device Directive, and has served numerous international compliance programs. Maier helps clients determine the most appropriate regulatory pathways and strategies to bring devices to market, and conducts regulatory troubleshooting and compliance audits for product files, clinical investigation files and quality systems. He holds an MBA in corporate management and a masters in medical engineering. He earned the RAC Devices in 2019. Maier is a member of several standardization committees related to medical devices. He is frequent speaker at international events for medical devices, quality and regulatory affairs topics.
Irena Milobratovic Irena Milobratovic is a senior regulatory affairs manager at Arriello. She has more than 15 years combined experience in pharmaceutical and medical device regulatory affairs, pharmacovigilance and market access. Milobratovic’s expertise lies within the processes which establish and keep Marketing Authorisation Holders compliant, such as medicinal products release to market, product information, labeling and regulatory compliance, as well as liaising with European and global health authorities. She has a masters of pharmacy and holds the RAC (EU) credential. Milobratovic is an active RAPS and RAPS European Council member.
Pallavi Trivedi, RAC Pallavi Trivedi has 20 years of executive career experience in regulatory affairs in world-class enterprises, multi-national organizations and entrepreneurial ventures in the pharmaceuticals industries, Pallavi is an expert in leading global regulatory strategy and product development. She is adept in strategic leadership of global registrations, compliance and life cycle management with a proven success record in handling a variety of complex biopharmaceuticals, food supplements and consumer healthcare products throughout the product life cycle. Pallavi is a result focused and detail-oriented professional with demonstrated success in building & motivating high performing teams.
Robert van Boxtel Robert van Boxtel is Principal Consultant at Medical Device Project B.V. and management team member. For 10 years, he supports the medical device industry on regulatory and quality related issues. Additionally he provides training to the industry, Notified Bodies and Competent Authorities on the MDR, ISO 13485, Risk Management, auditing etc. Over the last 2 years he is board member of RAPS Netherlands Chapter and is involved in organizing the RAPS meetings. He participates in several MDR implementation discussion groups and is hired by the Royal Dutch Standards Institute (NEN) as trainer. He participates in TC210 in the working groups for quality management systems, risk management, PMS and the Dutch horizontal standards committee. Before, he worked at Notified Body KEMA Quality (Now Dekra Certification) and in the industry in several roles in design and production, in both the EU as in USA.
Andreas Wiegand Andreas Wiegand is senior director of regulatory affairs at Siemens Health, where he built a dedicated group to handle US submissions for the company’s German-made products and directs the local regulatory team in charge of global submissions. After receiving a degree in Chemistry, he began his career in a lab developing IVD products and specialized in immunoassays. Weigand later worked in regulatory affairs for vaccines. He specialized in US regulatory affairs and earned the RAC (US), eventually broadening his responsibilities to cover worldwide registrations, including WHO prequalification. After working in countries including the US and the Netherlands, he returned to his native Germany, where he has been able to combine his experience with IVDs and regulatory affairs.
Anja Wiersma, PhD Anja Wiersma is a medical biologist by training with a PhD in the neuropharmacological—behavioral—physiology field. She worked for eight years at the multinational pharmaceutical company, Organon, first as scientific researcher and later as a strategist, and spent more than six years at a notified body in the medical devices and in vitro diagnostics (IVD) fields. Wiersma is fully qualified as a notified body auditor in the EU for both the Medical Device Directive and the IVD Directive. She is a regulatory and quality consultant for device and IVD manufacturers and contractor for notified bodies executing design dossier reviews and CE and ISO 13485 audits as well as for executing inspections for independent organizations. Wiersma is board chair of the RAPS Netherlands Chapter a member of the RAPS European Council.
It’s Your Time. Learn Wisely.
An individual certification for our global industry
Join the ranks of the most successful regulatory professionals with your RAC. This accredited credential is the only globally recognised certification for the regulatory industry.
The RAC highlights your knowledge through a sector-specific lens. Where is your expertise?
Regulatory Focus is the leading source for quality, timely, regulatory news, information and analysis.